![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/16 | |
A61K 49/00 | |||
G01N 33/53 | |||
C12Q 1/42 | |||
C12P 21/06 | |||
C12N 1/21 | |||
G01N 33/68 | |||
A61K 38/00 | |||
A61K 38/10 | |||
C07K 14/00 | |||
C07K 7/00 | |||
A61P 9/00 | |||
A61P 9/12 | |||
A61P 13/12 | |||
A61P 19/00 | |||
C07K 14/58 | |||
A61K 47/48 |
(11) | Number of the document | 2432489 |
(13) | Kind of document | T |
(96) | European patent application number | 10778389.6 |
Date of filing the European patent application | 2010-05-20 | |
(97) | Date of publication of the European application | 2012-03-28 |
(45) | Date of publication and mention of the grant of the patent | 2016-10-05 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/035586 |
Date | 2010-05-20 |
(87) | Number | WO 2010/135541 |
Date | 2010-11-25 |
(30) | Number | Date | Country code |
180112 P | 2009-05-20 | US | |
254563 P | 2009-10-23 | US |
(72) |
WENDT, Daniel, J., US
AOYAGI-SCHARBER, Mika, US
LONG, Shinong, US
VELLARD, Michel, Claude, US
CASTILLO, Sianna, US
OKHAMAFE, Augustus, O., US
PRICE, Christopher, P., US
|
(73) |
BioMarin Pharmaceutical Inc.,
105 Digital Drive, Novato, CA 94949,
US
|
(54) | VARIANTS OF C-TYPE NATRIURETIC PEPTIDE |
VARIANTS OF C-TYPE NATRIURETIC PEPTIDE |